perfluorohexyloctane 1340 MG/ML Ophthalmic Solution
- RxCUI
- 2637551
- RxNorm name
- perfluorohexyloctane 1340 MG/ML Ophthalmic Solution
- Display name
- perfluorohexyloctane 1340 MG/ML Ophthalmic Solution
- Full name
- perfluorohexyloctane 1340 MG/ML Ophthalmic Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:02
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MIEBO | PERFLUOROHEXYLOCTANE | Bausch & Lomb Incorporated | 6b283c02-7df4-4c00-951b-555cddffe77c | 2026-03-10 | Warnings, Adverse reactions | 2637551 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6b283c02-7df4-4c00-951b-555cddffe77c | perfluorohexyloctane 1.338 GM/mL Ophthalmic Solution [PSN] · perfluorohexyloctane 1340 MG/ML Ophthalmic Solution [SCD] · perfluorohexyloctane 1.338 GM/ML Ophthalmic Solution [SY] | 3 | 12 | These highlights do not include all the information needed to use MIEBO safely and effectively. See full prescribing information for MIEBO. MIEBO ® (perfluorohexyloctane ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2023 | 20260310 |